Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Aldeyra Therapeutics, Inc. (ALDX) had Current Liabilities of $27.81M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-33.85M |
|
-- |
|
-- |
|
$35.27M |
|
$-35.27M |
|
$1.42M |
|
$-33.85M |
|
$-33.85M |
|
$-33.85M |
|
$-33.85M |
|
$-33.85M |
|
$-33.85M |
|
$-35.27M |
|
$-36.16M |
|
60.06M |
|
60.06M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$71.78M |
|
-- |
|
$0.28M |
|
$72.06M |
|
|
Current Liabilities |
$27.81M |
-- |
|
-- |
|
$27.81M |
|
$44.25M |
|
$44.25M |
|
$44.25M |
|
60.16M |
|
| Cash Flow Statement Financials | |
$-33.35M |
|
$47.74M |
|
$1.12M |
|
$54.53M |
|
$70.04M |
|
$15.51M |
|
$6.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.58 |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-76.49% |
|
-76.49% |
|
-46.97% |
|
-76.49% |
|
$0.74 |
|
$-0.56 |
|
$-0.56 |
|